What is a stock summary page? Click here for an overview.
Business Description
Kodiak Sciences Inc
NAICS : 325412
SIC : 2834
ISIN : US50015M1099
Description
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.39 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.47 | |||||
| Debt-to-EBITDA | -0.47 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 17.1 | |||||
| 3-Year EPS without NRI Growth Rate | 13.4 | |||||
| 3-Year FCF Growth Rate | 22.1 | |||||
| 3-Year Book Growth Rate | -39.4 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.99 | |||||
| 9-Day RSI | 39.51 | |||||
| 14-Day RSI | 34.7 | |||||
| 3-1 Month Momentum % | -52.28 | |||||
| 6-1 Month Momentum % | 29.06 | |||||
| 12-1 Month Momentum % | -3.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.72 | |||||
| Quick Ratio | 6.72 | |||||
| Cash Ratio | 6.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | 6.47 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -83.34 | |||||
| ROA % | -43.53 | |||||
| ROIC % | -100.01 | |||||
| 3-Year ROIIC % | 8642.46 | |||||
| ROC (Joel Greenblatt) % | -108.87 | |||||
| ROCE % | -46.7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1 | |||||
| Price-to-Tangible-Book | 1 | |||||
| EV-to-EBIT | -0.3 | |||||
| EV-to-Forward-EBIT | -0.27 | |||||
| EV-to-EBITDA | -0.35 | |||||
| EV-to-Forward-EBITDA | -0.3 | |||||
| EV-to-FCF | -0.44 | |||||
| Earnings Yield (Greenblatt) % | -333.33 | |||||
| FCF Yield % | -78.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kodiak Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -3.112 | ||
| Beta | 0.44 | ||
| 3-Year Sharpe Ratio | 0.2 | ||
| 3-Year Sortino Ratio | 0.34 | ||
| Volatility % | 141.37 | ||
| 14-Day RSI | 34.7 | ||
| 14-Day ATR (€) | 0.171475 | ||
| 20-Day SMA (€) | 2.3125 | ||
| 12-1 Month Momentum % | -3.21 | ||
| 52-Week Range (€) | 1.724 - 10.75 | ||
| Shares Outstanding (Mil) | 52.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kodiak Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kodiak Sciences Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kodiak Sciences Inc Frequently Asked Questions
What is Kodiak Sciences Inc(FRA:K27)'s stock price today?
The current price of FRA:K27 is €1.99. The 52 week high of FRA:K27 is €10.75 and 52 week low is €1.72.
When is next earnings date of Kodiak Sciences Inc(FRA:K27)?
The next earnings date of Kodiak Sciences Inc(FRA:K27) is 2025-05-15 Est..
Does Kodiak Sciences Inc(FRA:K27) pay dividends? If so, how much?
Kodiak Sciences Inc(FRA:K27) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers